CCM
AVNS

Channing Capital Management’s Avanos Medical AVNS Stock Holding History

Channing Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-424,782
Closed -$18.1M – 115
2019
Q1 		$18.1M Sell
424,782
-471,056
-53% -$21.1M 0.84% 40
2018
Q4 		$40.1M Sell
895,838
-67,797
-7% -$3.55M 2.01% 20
2018
Q3 		$66M Sell
963,635
-157,583
-14% -$10.1M 2.38% 18
2018
Q2 		$64.2M Sell
1,121,218
-84,460
-7% -$4.46M 2.27% 15
2018
Q1 		$55.6M Buy
1,205,678
+633,763
+111% +$30.1M 1.95% 24
2017
Q4 		$26.4M Buy
+571,915
New +$26.3M 0.89% 38

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Channing Capital Management's AVNS Position: Q2 2019 in Review

Channing Capital Management sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 424,782 shares — an estimated $18.1M sold.

Channing Capital Management first reported a position in AVNS in Q4 2017 and held it in 6 quarters. The position peaked at $66M in Q3 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Channing Capital Management reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Channing Capital Management sold 424,782 Avanos Medical shares in Q2 2019, an estimated $18.1M.
  • Channing Capital Management first reported a position in Avanos Medical in Q4 2017 and held it in 6 quarters.
  • Channing Capital Management's Avanos Medical position peaked at $66M in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Channing Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.